Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

Bioventus Inc. (BVS) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $15.09 Metrics
OS: 78.6 M -137 % ROE
Market cap: $1.19 B -16 % ROIC
Net debt: $350 M 8.2 x Debt/EBITDA
EV: $1.54 B

 
TTM Valuation
EBITDA $42.8 M 35.9 x EV/EBITDA
EBIT ($30.2) M
EPS ($3.96)

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-14Dec-31-13
Revenues512431321340319  
            Revenue growth18.8%34.2%-5.6%6.6%   
Cost of goods sold202140959784  
Gross profit310291226243235  
            Gross margin60.6%67.4%70.4%71.4%73.6%  
Selling, general and administrative333254193198192  
Research and development261911118  
EBITA1851495827  
            EBITA margin3.6%11.8%15.4%17.1%8.3%  
Amortization of intangibles67352826   
EBIT-4915223227  
            EBIT margin-9.5%3.6%6.8%9.3%8.3%  
Pre-tax income-264816106  
Income taxes-51-2122  
            Tax rate19.1% 7.5%16.3%27.2%  
Earnings from continuing ops-1591916134  
Earnings from discontinued ops   217  
Net income-159191615-12  
            Net margin-31.0%4.5%5.1%4.4%-3.8%  
 
Diluted EPS($2.59)$0.43$14,722.00$1.27$1.14  
Shares outstanding (diluted)61450104  
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy